<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03398369</url>
  </required_header>
  <id_info>
    <org_study_id>UVAMRICRTTRIAL</org_study_id>
    <nct_id>NCT03398369</nct_id>
  </id_info>
  <brief_title>Randomized Clinical Trial of MRI for Optimal CRT Outcomes</brief_title>
  <official_title>Randomized Clinical Trial of MRI for Optimal CRT Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a clinical trial of CMR guidance for the CRT procedure. Patients will be randomized
      to CMR guidance or standard care for the CRT procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      At baseline, patients will have CMR, echocardiography, and cardiopulmonary exercise testing.
      In patients randomized to CMR guidance for the CRT procedure, LV lead placement will be
      guided by the MRI information related to scar, activation and anatomy. Patients will have
      follow-up assessments at 6 and 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 5, 2018</start_date>
  <completion_date type="Anticipated">January 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 15, 2022</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Left ventricular end-systolic volume (LVESV) improvement</measure>
    <time_frame>One Year</time_frame>
    <description>Change in LVESV with cardiac resynchronization therapy (CRT)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Heart Failure, Systolic</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MRI-Guided CRT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard CRT</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MRI-Guided CRT</intervention_name>
    <description>MRI-Guided CRT</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. chronic systolic HF

          2. LVEF 35% or less, and a guideline-based class I or II indication for CRT 3) 3) They
             must be between 20 and 90 years old

        4) Predominantly in sinus rhythm 5) The GFR must be at least 45 cc/min if the patient is to
        receive gadolinium

        Exclusion Criteria:

          1. inability to provide informed consent

          2. pregnancy

          3. presence of metal embedded in the body due to prior accident or injury, as documented
             by skull films or other imaging;

          4. cerebral aneurysm clips

          5. gadolinium contrast allergy (only if gadolinium is given)

          6. cochlear implants

          7. other metallic implants known to be contraindications to MRI

          8. severe claustrophobia

          9. acute kidney injury

         10. acute renal failure or chronic kidney disease with GFR &lt; 40 cc/min

         11. liver transplant

         12. gadolinium contrast allergy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth C Bilchick, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia Health System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kenneth C Bilchick, MD</last_name>
    <phone>4349242465</phone>
    <email>bilchick@virginia.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hollis Phillips, BA</last_name>
    <phone>434-243-0046</phone>
    <email>hp9r@hscmail.mcc.virginia.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Virginia Health System</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Hoover</last_name>
      <phone>434-243-4861</phone>
      <email>jrh5r@hscmail.mcc.virginia.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 7, 2018</study_first_submitted>
  <study_first_submitted_qc>January 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 12, 2018</study_first_posted>
  <last_update_submitted>January 18, 2018</last_update_submitted>
  <last_update_submitted_qc>January 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Virginia</investigator_affiliation>
    <investigator_full_name>Kenneth Bilchick, MD</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Failure, Systolic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

